Background {#Sec1}
==========

It has been reported that endonasal dacryocystorhinostomies (EN-DCRs) yields good esthetic, functional results and similar success rate to that of the external dacryocystorhinostomies (EX-DCRs) \[[@CR1]--[@CR5]\]. By simulating EX-DCRs in EN-DCRs (mainly in two aspects: 1 maximizing bone window and complete exposure of the inside wall of larimal sac; 2 Ensuring anatomical overlap of the lacrimal sac and nasal mucosal flap), the EN-DCRs can achieve similar successful rates to EX-DCRs \[[@CR6], [@CR7]\]. But for the cases of small sac who have lacrimal sac mucosa fibrosis and mucosa scarring resulting from limited residual sac mucosa caused by previous DCRs, the success rate of revision DCR is significantly reduced regardless of the surgical approaches \[[@CR8], [@CR9]\]. One of the most important reasons is that it is difficult to form lacrimal sac mucosal flap and nasal mucosa flap anatsatomosis, which causes stoma scarring and resultant surgical failure. Those patients often require repeated revision DCRs, and the revision DCRs often require special surgical approach such as agger nasi cell mucosal autograft for lacrimal sac reconstruction or mucosal grafting \[[@CR10], [@CR11]\]. A recent retrospective review has reported that powered EN-DCR is a suitable option for revising failed DCRs in which yields good long-term results \[[@CR3]\]. Inserting silicone tubes through the inferior and the superior puncta significantly improved the successful rate of revision DCR \[[@CR2], [@CR4]\]. However, silicone tubes were too thin to induce the closure of newly performed ostia for patients with the risk factors of failure. To improve the current EN-DCR procedure, we have inserted an otologic T-type tube in addition to silicone tube into the lacrimal sac cavity., and we have achieved a higher success rate than conventional EN-DCR with careful treatment after surgery.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

This is a prospective study where 22 patients who had previously undergone at least once failed EN-DCR were enrolled in our study during January 2008 to December 2011. The main symptoms of all patients were epiphora. All patients were given a detailed ophthalmic and otolaryngologic examination preoperatively. The former included lacrimal probe and rinse to eliminate canalicular and tear duct obstruction. The latter included a detailed nasal endoscopy to determine whether there were nasal abnormalities such as high deviated septum, which might influence the surgery effect \[[@CR12]\]. All the operations, including the last revision DCR, were performed by the same surgeon. In addition, 22 patients who received conventional EN-DCR only were included as control.

The study was approved by the Ethical Committee of The Second People's Hospital of Wuxi. Informed consents were obtained from all individuals included in the study.

Surgical technique {#Sec4}
------------------

EN-DCR was performed under general anesthesia. After decongestion and vasoconstriction of the nasal mucosa with packing of 1/1000 adrenaline solution, an elbow probe was used to determine the exact location of the last bone window. Under endoscopic visualization with a 30° endoscope, a curved mucosal flap incision was carried 0.5 cm more anteriorly over the front edge of bone window. When necessary, the bone window was enlarged with a 15° medtronic sac drill until complete sac exposure was obtained including inside wall. A lacrimal probe was inserted through the inferior punctum into sac, the median wall of the sac was pushed into the nasal cavity. The medial 1\*1 cm section of the median wall of the lacrimal sac was excised upon the mucosal incision with the sickled blade. Silicone tube needles which were inserted through the inferior and the superior puncta were grasped in the nasal cavity, followed by the insertion of the T-type ventilation tube using micro-alligator forceps, which were commonly used in ear surgery (Fig. [1](#Fig1){ref-type="fig"}). T-type ventilation tube was set out of the silicone tube when assistant pulled the two ends of the silicone tube. A gun-shaped clamp was used to make the T-type tube gradually sliding towards the sac. Two feet of T-tube was unfolded into sac with probes and was clipped with titanium clips to prevent it from falling off. Normal mucosa was reset and make sure there was no active bleeding. One patient who underwent deviated septum surgery was given nasal packing, and the rest were given no nasal packing.Fig. 1Surgical techniques. **a** Silicone tube needles inserted through the inferior and the superior puncta grasped in the nasal cavity (*right*). **b** Insertion of the T-type ventilation tube (*black arrow*) using micro-alligator forceps. T-type ventilation tube was set out of the silicone tube. **c** A gun-shaped clamp was used to make the T-type tube gradually sliding towards the sac. **d** The ostium status in referral visit after removing T-tube

Postoperative disposition {#Sec5}
-------------------------

Postoperatively, the nasal packing material was removed 2 days later, and the patients were given oral antibiotics for 7 days, antibiotic eyedrops for 15 days, nasal steroids for 3 weeks, and oral antihistamines for a week. Patients were followed up every 2 weeks to report any symptoms, to remove scars, granulation tissue, and possible synechiae under endoscopy until the occurrence of complete local epithelialization. Check whether the T-tube prolapse out of sac and reset the tube if it prolapses. If no partial granulation or adhesion, and smooth stoma was observed in 2 consecutive endoscopies, T-tube was removed. To remove T-tube, silicone tube was cut at innur canthus, and then the T-tube was removed together with the silicone tube under endoscopy. Lacrimal irrigation was carried out weekly for the first month, and twice a month since then. The evaluation of the success was conducted at two time points: 1, disappearance of patients' symptoms; 2, no reflux in lacrimal irrigation.

Statistical analyses {#Sec6}
--------------------

Statistical analyses were performed using GraphPad Prism v5.0 (Graphpad Software Inc.). Two sample test or Chi-square test was used for comparison of qualitative data. A *p* \< 0.05 was considered to be statistically significant.

Results {#Sec7}
=======

Modified revision EN-DCR was performed on 22 patients (7 male and 15 female), and the average age for those patients at the time of revision was 44.5 years (range from 26 to 68 years; SD, 15.1). Of those patients, 15 cases have previously undergone revision EN-DCRs twice, and 2 cases have undergone revision EN-DCRs three times. The patients have previously undergone either EX-DCR or EN-DCR, but the latest surgery of all patients was EN-DCR. The time from last failed DCR to recurrence of epiphora varied from 5 to 37 months with a mean time of 12 months. The main causes of previous failure were membranous scarring over ostium (8/22), ostium closure (5/22), or wall of lacrimal sac thickness and fibrosis (9/22) (Table [1](#Tab1){ref-type="table"}). In parallel, 22 patients who received conventional EN-DCR were included as a control group. There were no significant differences in age or gender distribution between the experimental and control groups (Table [2](#Tab2){ref-type="table"}). Of these patients, 18 cases have previously undergone revision EN-DCRs twice and 1 case has undergone revision EN-DCRs three times. The time from last failed DCR to recurrence of epiphora varied from 6 to 35 months with a mean time of 12.5 months (Table [3](#Tab3){ref-type="table"}).Table 1General characteristics of patients receiving modified revision EN-DCRCaseSideType of failed DCR and yearTime from last failed DCR to recurrence of epiphora (months)Cause(s) of failureThe times of tube prolapsethe duration of tube intubation(weeks)1LEX 2006\
EN 200715Membranous scarring over ostium062REX 2004\
EN 200618Wall of lacrimal sac thickness and fibrosis183REX 2002\
EN 200537Ostium closure0154LEX 2003\
EX 2005\
EN 200825Membranous scarring over ostium0205LEN 2007\
EN 20088Ostium closure1146REX 2007\
EN 20097Wall of lacrimal sac0187REX 2006\
EX 2008\
EN 201010Membranous scarring over ostium288LEN 2009\
EN 20106Membranous scarring over ostium0109LEX 20099Ostium closure31310REN 2009\
EN 20105Wall of lacrimal sac thickness and fibrosis01411LEN 2008\
EN 200912Wall of lacrimal sac thickness and fibrosis01812REN 20098Wall of lacrimal sac thickness and fibrosis01513REN 2003\
EN 200510Ostium closure22014LEX 2007\
EN 200912Membranous scarring over ostium31015LEX 20086Membranous scarring over ostium21516LEN 2005\
EN 20095Wall of lacrimal sac31317LEX 2008\
EN 20108Ostium closure11218REN 2004\
EN 200910Wall of lacrimal sac11119REN 2005\
EN 200813Membranous scarring over ostium2820REX 2005\
EN 200816Membranous scarring over ostium3621LEX 2006\
EN 20089Wall of lacrimal sac2622LEN 20097Wall of lacrimal sac012Age range: 26--68; Number of male: 7; Number of female: 15 Table 2Comparison of demographics of modified revision EN-DCR and conventional ENDCR GroupsVariablesModified EN-DCREN-DCR*P* ValueAge (yrs)Mean44.546.3\> 0.8^a^Standard deviation15.116.3Gender, n (%)Male7 (31.8)10 (45.4)\> 0.8^b^Female15 (68.2)12 (54.6)^a^t test^b^Chi-square test Table 3General characteristics of patients receiving conventional revision EN-DCRCaseSideType of failed DCR and yearTime from last failed DCR to recurrence of epiphora (months)Cause(s) of failure1REX 2006\
EX 200716Ostium closure2REX 2004\
EN 200622Wall of lacrimal sac thickness and fibrosis3LEN 2002\
EX 200519Ostium closure4REX 2003\
EN 200825Membranous scarring over ostium5LEX 2007\
EN 200835Ostium closure6LEX 2007\
EN 200914Wall of lacrimal sac7REN 2006\
EX 2008\
EN 200612Membranous scarring over ostium8LEX 2009\
EN 20108Membranous scarring over ostium9REX 2009\
EN 20097Wall of lacrimal sac thickness and fibrosis10REN 2009\
EN 20109Wall of lacrimal sac thickness and fibrosis11LEN 2008\
EN 200912Ostium closure12LEN 200912Wall of lacrimal sac thickness and fibrosis13REN 2003\
EN 200511Wall of lacrimal sac14REX 2007\
EN 20096Ostium closure15REX 20088Membranous scarring over ostium16LEN 2005\
EN 2009\
EX 20087Wall of lacrimal sac17LEX 2008\
EN 20109Ostium closure18LEN 2004\
EN 200711Wall of lacrimal sac19REN 2008\
EN 200612Membranous scarring over ostium20LEX 2007\
EN 200914Wall of lacrimal sac21REX 2008\
EN 20098Membranous scarring over ostium22LEN 20077Wall of lacrimal sacAge range: 31--66; Number of male: 8; Number of female: 14

All patients felt the symptom of epiphora, nasal secretions and foreign body sensation. However, these symptoms disappeared after the T-tubes were removed. In the postoperative follow-up visits, 8 patients reported alleviated epiphora before the tube was removed, and 6 patients reported foreign body sensation in nasal cavity or inner canthus with increased nasal secretion. In referral, T-tube was found prolapsed in 9 patients among whom 5 cases prolapsed once, 3 cases prolapsed twice, 1 case prolapsed three times. The tubes were successfully reset whenever prolapses were observed. The duration of tube intubation varied from 6 to 20 weeks, with a mean time of 12.5 weeks. The follow-up time varied from 2 to 3 years with a mean time of 2.3 years. After removing T-tube, 3 patients reported mild epiphora when they felt fatigue in cold weather, but the symptoms disappeared after eyedrops and lacrimal. In the group who underwent modified EN-DCR, 3 patients had complications with 2 cases with eyelid edema which disappeared 1 week after operation and 1 case with appearance of granulation tissue formation surrounding the T-tubes which were cleared under endoscope. In most patients, crusts were found to be formed surround the T-tubes, which were cleared and cleaned with nasal saline in follow-up visits. Eyelid edema and bleeding spots typically recovered 1 week after surgery without interference. In the patients undergoing conventional DCR, 6 patients suffered from eyelid edema and 8 patients reported bleeding spots, and 4 patients experienced epiphora, significantly higher than modified EN-DCR (90.0% vs 13.6%, *P* \< 0.0001) (Table [4](#Tab4){ref-type="table"}).Table 4Appearance of complications in modified revision EN-DCR and conventional ENDCR GroupsComplicationsModified EN-DCR\
N (%)EN-DCR\
N (%)*P* ValuePresent3 (13.6)20 (90.9)\<0.0001^a^Absent19 (86.4)2 (9.1)^a^Chi-square test

Table [5](#Tab5){ref-type="table"} summarized surgical outcomes 2 years after surgery. Anatomical success was achieved in 100% (22/22) of modified EN-DCR and 40.9% (9/22) of conventional EN-DCRs. Functional success was observed in 90.9.0% (20/22) of modified EN-DCR and 22.7% (5/22) of EN-DCR. The difference in surgical outcomes between these two surgeries was statistically significant with a two-sample test for equality of proportions with continuity correction (*P* \< 0.01). With 44 study patients, the power of this test is 80% with α = 0.05 to detect a clinically significant decrease in the success rate of 8%.Table 5Outcome for modified revision EN-DCR and conventional EN-DCR GroupsVariablesModified EN-DCR\
N (%)EN-DCR\
N (%)*P* ValueAnatomical success22 (100)9 (40.9)\<0.01^aa^Two-sample test for equality of proportions with continuity correction; Power = 80% for α = 0.05 to detect a decreased success rate of 8%

Discussion {#Sec8}
==========

In the present study, we slightly modified the approach where an otologic T-tube combined with silicone tube intubation was applied in EN-DCRs. Compared with silicone tube intubation only, this combined approach significantly improved the successful rate. This improvement may be due to the fact that T-tube acts as a support for residual sac mucosa, and it promotes the anastomosis of nasal and lacrimal sac mucosa, which results in spacious and long-lasting channel formation between the sac and nasal cavity, thus easing the ostium stenosis and closure caused by gradual contraction. No severe complications, such as orbital injury, occurred during operation for any of the patients, the incidence of minor postoperative complications such as eyelid edema and bleeding spots were lower than the control group, who have only undergone conventional EN-DCR by the same surgeon.

The closure of newly created ostium is the common cause of failure. It is generally accepted that the size of the excised lacrimal bone and created ostium is important for the long-term outcomes \[[@CR5]\]. If the bone window is large enough, the sac is fully exposed, and the anastomosis of nasal and lacrimal sac mucosa flaps is fully achieved, most revision DCRs do not require additional T-tube implants since it prolongs the operation time and adds on additional expense for patients. Moreover, some patients may feel discomfort in the nose and inner canthus caused by T-tube implants. But for patients with high risk of failure such as those with small sac, lacrimal sac mucosa fibrosis and scarring or limited residual sac mucosa, T-tube combined with silicone tube intubation is a better alternative than conventional EN-DCRs.

Conclusions {#Sec9}
===========

Our modified procedure achieved both anatomical success rate and functional success rate with lower occurrence of minor complications. The functional success rate was lower than the anatomical success rate probably due to systolic dysfunction of the remnants of lacrimal sac and the poor siphon function of lacrimal point. While we appreciate the moderate success rate of current EN-DCR, we believe that for the revision EN-DCR, T-tube combined with silicone tube intubation needs to be improved due to the two reasons: firstly, it is needed to establish some objective indicators for the combined intubation; secondly, the otologic T-tube we applied was used for the treatment of secretory otitis media but not specifically for DCR. We believe if we can further optimize the material and structure of T-tube to make it more suitable for the application in the lacrimal sac, there will be more widely usage of T-tube in DCR.
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